Likely gains in life expectancy of patients with coronary artery disease treated with HMG-CoA reductase inhibitors, as Predicted by a decision analysis model

European Journal of Surgery

Volumn 163, Issue 7, 1997, Pages 539-546

  Kellett, John ^a  

^a St Joseph's General Hospital Nenagh   (Ireland)

Author keywords

Coronary artery bypass surgery; Lipid lowering agents; Markov process; Pravastatin; Simvastatin

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DECISION THEORY; HUMAN; LIFE EXPECTANCY; PRIORITY JOURNAL; QUALITY OF LIFE;

ACYL COENZYME A; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE;

EID: 0030795658     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Barbir M, Hunt BJ, Galloway D, et al. A randomized pilot trial of lowdose combination lipid-lowering therapy following coronary artery bypass grafting. Clin Cardiol 1994; 17: 59-64.
2. Brown BG, Zhao X-Q, Sacco DE, Albers JJ. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993; 87: 1781-1791.
3. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal thoracic artery grafts: effects on survival over a 15 year period. N Engl J Med 1996; 334: 216-219.
4. CASS Principal Investigators and their Associates. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: survival data. Circulation 1983; 68: 939-950.
5. Chaitman BR, Ryan TJ, Kronmal RA, Foster ED, Frommer PL, Killip T, the CASS Investigators. Coronary artery surgery study (CASS): comparability of 10 year survival in randomized and randomizable patients. J Am Coll Cardiol 1990; 16: 1071-1078.
6. Davies MJ, Krikler DM, Katz D. Atherosclerosis: inhibition or regression as therapeutic possibilities. Br Heart J 1991; 65: 302-310.
7. European Coronary Surgery Study Group. Long-term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982; ii: 1173-1180.
8. Fiore AC, Naunheim KS, Dean P, et al. Results of internal thoracic artery grafting over 15 years: single versus double grafts. Ann Thorac Surg 1990; 49: 202-208.
9. Fuster V, Badimon L, Badimon JJ, Chesebro JH. Mechanisms of disease: the pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts). N Engl J Med 1992; 326: 242-250.
10. Fuster V, Badimon L, Badimon JJ, Chesebro JH. Mechanisms of disease: the pathogenesis of coronary artery disease and the acute coronary syndromes (Second of two parts). N Engl J Med 1992; 326: 310-318.
11. Gardener TJ, Horneffer PJ, Manolio TA, Hoff SJ, Pearson TA. Major stroke after coronary artery bypass surgery: changing magnitude of the problem. Vasc Surg 1986; 3: 684-687.
12. Grondin CM, Campeau L, Thornton JC, Engle JC, Cross FS, Schreiber H. Coronary artery bypass grafting with saphenous vein. Circulation 1989; 79: 124-129.
13. Hammermeister KE, DeRouen TA, Dodge HT. Comparison of survival of medically and surgically treated coronary disease patients in Seattle Heurt Watch: a nonrandomized study. Circulation 1982; 65: 53-59.
14. Kellett JG. The outcome of coronary artery bypass surgery as predicted by decision analysis: the influence of age, disease severity and ventricular function. Theoret Surg 1992; 7: 57-75.
15. Lawrie GM, Morris GC, Baron A, Norton J, Glaeser DH. Determinants of survival 10 to 14 years after coronary bypass: analysis of preoperative variables in 1,448 patients. Ann Thorac Surg 1987; 44: 180-185.
16. Lawrie GM, Morris GC, Earle N. Long-term results of coronary bypass surgery. Ann Surg 1991; 213: 377-387.
17. Mock MB, Ringquist I, Fisher LD, et al, participants in the Coronary Artery Surgery Study. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1982; 66: 562-568.
18. Muhlbaier LH, Pryor DB, Rankin JS, et al. Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease: 20 years of follow-up. Circulation 1992; 86(suppl II): 198-204.
19. Proudfit WL, Bruschke AVG, MacMillan JP, Williams GW, Sones FM. Fifteen year survival study of patients with obstructive coronary artery disease. Circulation 1983; 68: 986-987.
20. Proudlit WL, Kramer JR, Goormastic M, Loop FD. Ten-year survival of patients with mild angina or myocardial infarction without angina: a comparison of medical and surgical treatment. Am Heart J 1990; 119: 942-948.
21. Rahimtoola SH, Fessler CL, Grunkemeier GL, Starr A. Survival 15 to 20 years after coronary artery bypass surgery for angina. J Am Coll Cardiol 1993; 21: 151-157.
22. Report on Vital Statistics 1986. Department of Health, Ireland. Dublin: Stationery Office, 1989.
23. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
24. Scandinavian Simvastatin Survival Study Group. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet 1995; 345: 1274-1275.
25. Shepherd J, Cobbe SM, Ford I, et al, for the West of Scotland Coronary Prevention Study Group N Engl J Med 1995; 333: 1301-1307.
26. Sox HC, Blatt MA, Higgins MC, Marton KI Medical decision making. Boston: Butterworth 1988: 147-237.
27. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993; 13: 322-338.
28. Ulicny KS, Flege JB, Callard GM, Todd JC. Twenty-year follow-up of saphenous vein aortocoronary artery bypass grafting. Ann Thorac Surg 1992; 53: 258-562.
29. Van Brussel BL, Plokker HW, Ernst SM, et al. Venous coronary artery bypass surgery. A 15-year follow-up study. Circulation 1993; 88: II87-II92.
30. Varnauskas E, the European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988; 319: 332-337.
31. Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984; 311: 1333-1339.
32. Vos J, deFeyter J, Simoons ML, Tiijssen JGP, Deckers JW. Retardation and arrest of progression or regression of coronary artery disease: a review. Prog. Cardiovasc Dis 1993; 35: 435-454.
33. Waters D, Craven T, Lesperance J. Prognostic significance of progression of coronary atherosclerosis. Circulation 1993; 87: 1067-1075.
34. Wong JB, Sonnenberg FA, Salem DN, Pauker SG. Myocardial revascularization for chronic stable angina: analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med 1990; 113: 852-871.
35. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials. Lancet 1994; 344: 563-570.